Preparation, characterization and transfection efficiency of cationic PEGylated PLA nanoparticles as gene delivery systems

被引:79
作者
Chen, Jiji
Tian, Buning
Yin, Xiang
Zhang, Yanqiong
Hu, Duosha
Hu, Zhiyuan
Liu, Meizhou
Pan, Yifeng
Zhao, Jinfeng
Li, Hao
Hou, Can
Wang, Jiwei
Zhang, Yangde [1 ]
机构
[1] Cent S Univ, Xiangya Hosp, Natl Hepatobiliary & Enter Surg Res Ctr, Changsha 410008, Hunan, Peoples R China
[2] Cent S Univ, Xiangya Hosp, Natl Key Lab Nanobiol Technol, Changsha 410008, Hunan, Peoples R China
[3] Cent S Univ, Xiangya Med Coll, Changsha 410008, Hunan, Peoples R China
基金
中国国家自然科学基金;
关键词
gene delivery; nanoparticle; PEGylated; polylactic acid (PLA); chitosan; CHITOSAN-DNA NANOPARTICLES; BRAIN DELIVERY; DRUG-DELIVERY; ACTIVATION; COMPLEXES; RELEASE;
D O I
10.1016/j.jbiotec.2007.02.007
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 [微生物学]; 090105 [作物生产系统与生态工程];
摘要
The cationic polylactic acid (PLA) nanoparticle has emerged as a promising non-viral vector for gene delivery because of its biocompatibility and biodegradability. However, they are not capable of prolonging gene transfer and high transfection efficiency. In order to achieve prolonged delivery of cationic PLA/DNA complexes and higher transfection efficiency, in this study, we used copolymer methoxypolyethyleneglycol-PLA (MePEG-PLA), PLA and chitosan (CS) to prepare MePEG-PLA-CS NPs and PLA-CS NPs by a diatiltration method and prepared NPs/DNA complexes through the complex coacervation of nanoparticles with the pDNA. The object of our work is to evaluate the characterization and transfection efficiency of MePEG-PLA-CS versus PLA-CS NPs. The MePEG-PLA-CS NPs have a zeta potential of 15.7 mV at pH 7.4 and size under 100 nm, while the zeta potential of PLA-CS NPs was only 4.5 mV at pH 7.4. Electrophoretic analysis suggested that both MePEG-PLA-CS NPs and PLA-CS NPs with positive charges could protect the DNA from nuclease degradation and cell viability assay showed MePEG-PLA-CS NPs exhibit a low cytotoxicity to normal human liver cells. The potential of PLA-CS NI's and MePEG-PLA-CS NPs as a non-viral gene delivery vector to transfer exogenous gene in vitro and in vivo were examined. The pDNA being carried by MePEG-PLA-CS NPs, PLA-CS NI's and lipofectamine could enter and express in COS7 cells. However, the transfection efficiency of MePEG-PLA-CS/DNA complexes was better than PLA-CS/DNA and lipofectamine/DNA complexes by inversion fluorescence microscope and flow cytometry. It was distinctively to find that the transfection activity of PEGylation of complexes was improved. The nanoparticles were also tested for their ability to transport across the gastrointestinal mucosa in vivo in mice. In vivo experiments showed obviously that MePEG-PLA-CS/DNA complexes mediated higher gene expression in stomach and intestine of BALB/C mice compared to PLA-CS/DNA and lipofectamine/DNA complexes. These results suggested that MePEG-PLA-CS NPs have favorable properties for non-viral gene delivery. (c) 2007 Elsevier B.V. All rights reserved.
引用
收藏
页码:107 / 113
页数:7
相关论文
共 25 条
[1]
Development and brain delivery of chitosan-PEG nanoparticles functionalized with the monoclonal antibody OX26 [J].
Aktas, Y ;
Yemisci, M ;
Andrieux, K ;
Gürsoy, RN ;
Alonso, MJ ;
Fernandez-Megia, E ;
Novoa-Carballal, R ;
Quiñoá, E ;
Riguera, R ;
Sargon, MF ;
Çelik, HH ;
Demir, AS ;
Hincal, AA ;
Dalkara, T ;
Çapan, Y ;
Couvreur, P .
BIOCONJUGATE CHEMISTRY, 2005, 16 (06) :1503-1511
[2]
Effect of copolymer composition on the physicochemical characteristics, in vitro stability, and biodistribution of PLGA-mPEG nanoparticles [J].
Avgoustakis, K ;
Beletsi, A ;
Panagi, Z ;
Klepetsanis, P ;
Livaniou, E ;
Evangelatos, G ;
Ithakissios, DS .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2003, 259 (1-2) :115-127
[3]
Avgoustakis Konstantinos, 2004, Current Drug Delivery, V1, P321, DOI 10.2174/1567201043334605
[4]
PLGA nanoparticles in drug delivery: The state of the art [J].
Bala, I ;
Hariharan, S ;
Kumar, MNVR .
CRITICAL REVIEWS IN THERAPEUTIC DRUG CARRIER SYSTEMS, 2004, 21 (05) :387-422
[5]
Role of endogenous endonucleases and tissue site in transfection and CpG-mediated immune activation after naked DNA injection [J].
Barry, ME ;
Pinto-González, D ;
Orson, FM ;
McKenzie, GJ ;
Petry, GR ;
Barry, MA .
HUMAN GENE THERAPY, 1999, 10 (15) :2461-2480
[6]
Chitosans for gene delivery [J].
Borchard, G .
ADVANCED DRUG DELIVERY REVIEWS, 2001, 52 (02) :145-150
[7]
Chitosan-DNA nanoparticles: Effect on DNA integrity, bacterial transformation and transfection efficiency [J].
Bozkir, A ;
Saka, OM .
JOURNAL OF DRUG TARGETING, 2004, 12 (05) :281-288
[8]
CONWELL CC, 2005, ADV GENET, P1
[9]
Nonviral strategies for gene therapy [J].
Felgner, PL .
SCIENTIFIC AMERICAN, 1997, 276 (06) :102-106
[10]
Lectin-conjugated PEG-PLA nanoparticles: Preparation and brain delivery after intranasal administration [J].
Gao, XL ;
Tao, WX ;
Lu, W ;
Zhang, QZ ;
Zhang, Y ;
Jiang, XG ;
Fu, SK .
BIOMATERIALS, 2006, 27 (18) :3482-3490